United Therapeutics Corp. (UTHR)
527.92
+11.24
(+2.18%)
USD |
NASDAQ |
Aug 27, 16:00
527.92
0.00 (0.00%)
After-Hours: 17:20
United Therapeutics Price : 527.92 for Aug. 27, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | 515.60 | 522.02 | 513.98 | 516.68 | 254780.0 |
| Aug 25, 2026 | 516.07 | 520.66 | 515.54 | 518.53 | 876497.0 |
| Aug 24, 2026 | 513.12 | 514.30 | 508.15 | 512.88 | 323887.0 |
| Aug 21, 2026 | 523.23 | 528.02 | 512.29 | 513.12 | 415574.0 |
| Aug 20, 2026 | 524.15 | 529.26 | 517.88 | 521.00 | 440385.0 |
| Aug 19, 2026 | 525.47 | 535.77 | 522.04 | 529.14 | 432111.0 |
| Aug 18, 2026 | 510.42 | 519.21 | 508.56 | 518.27 | 366432.0 |
| Aug 17, 2026 | 502.29 | 509.54 | 499.96 | 508.48 | 457341.0 |
| Aug 14, 2026 | 498.91 | 501.62 | 494.34 | 499.73 | 472955.0 |
| Aug 13, 2026 | 515.62 | 515.62 | 499.19 | 501.27 | 408060.0 |
| Aug 12, 2026 | 510.44 | 521.43 | 506.01 | 511.72 | 326126.0 |
| Aug 11, 2026 | 528.06 | 534.41 | 512.47 | 515.50 | 343389.0 |
| Aug 10, 2026 | 528.60 | 540.56 | 523.37 | 529.66 | 642772.0 |
| Aug 07, 2026 | 534.84 | 541.03 | 524.58 | 538.84 | 1.199M |
| Aug 06, 2026 | 519.79 | 533.12 | 511.99 | 532.94 | 998775.0 |
| Aug 05, 2026 | 505.00 | 525.78 | 490.80 | 519.01 | 742762.0 |
| Aug 04, 2026 | 517.86 | 521.18 | 511.93 | 518.68 | 522267.0 |
| Aug 03, 2026 | 516.29 | 519.74 | 514.01 | 516.31 | 427627.0 |
| Jul 31, 2026 | 525.84 | 525.84 | 514.34 | 517.71 | 616617.0 |
| Jul 30, 2026 | 522.30 | 528.96 | 521.80 | 525.82 | 472491.0 |
| Jul 29, 2026 | 526.08 | 526.17 | 517.61 | 524.70 | 560581.0 |
| Jul 28, 2026 | 530.84 | 532.45 | 522.10 | 523.63 | 446331.0 |
| Jul 27, 2026 | 529.71 | 535.22 | 524.81 | 527.94 | 431349.0 |
| Jul 24, 2026 | 533.94 | 537.76 | 527.75 | 528.47 | 313248.0 |
| Jul 23, 2026 | 521.91 | 532.12 | 519.01 | 529.53 | 241123.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 69.89 |
| Insmed, Inc. | 121.36 |
| MannKind Corp. | 4.06 |
| Vertex Pharmaceuticals, Inc. | 547.48 |
| BioMarin Pharmaceutical, Inc. | 65.32 |
Price Related Metrics
| PE Ratio | 18.88 |
| PS Ratio | 7.849 |
| PEG Ratio | 2.061 |
| Price to Book Value | 3.520 |
| Price to Free Cash Flow | 22.84 |
| Earnings Yield | 5.30% |
| Market Cap | 22.53B |
| PEGY Ratio | 2.061 |
| Operating PE Ratio | 17.64 |
| Normalized PE Ratio | 20.24 |